FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and immunology, specifically to use of O-specific polysaccharide of marine bacteria Cobetia litoralis KMM 3890T (OPS 1) or O-specific polysaccharide of marine bacteria Idiomarina abyssalis KMM 227T (OSP 2) as an adjuvant for vaccines.
EFFECT: use of said polysaccharides enables inducing a T- and B-cell with a Th1/Th2 immune response profile in a mammalian body, id est they have considerable potential for amplification both cellular, and humoral immune answer without toxicity for an organism.
1 cl, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ADJUVANT FOR ANTI-VIRAL VACCINES | 2017 |
|
RU2676266C2 |
| ADJUVANT, BASED ON LOW-MOLECULAR PEPTIDOGLYCAN OF BACTERIAL CELL WALL | 2013 |
|
RU2563354C2 |
| IMPROVED IMMUNOLOGICAL COMPOSITION | 2012 |
|
RU2664730C2 |
| MUTANT ANTIGENS GAS57 AND GAS57 ANTIBODIES | 2008 |
|
RU2471497C2 |
| CHLAMYDIAL VACCINE AND METHOD FOR ITS PREPARATION | 2016 |
|
RU2676768C2 |
| PHARMACEUTICAL COMPOSITION OF PATTERN-RECOGNISING RECEPTOR LIGANDS, METHODS FOR USING IT AS IMMUNOSTIMULANT FOR TREATING INFECTION CAUSED BY BACTERIAL AND VIRAL PATHOGENS, METHOD FOR USING IT AS ADJUVANT OF VACCINES | 2012 |
|
RU2497541C1 |
| MEANS OF IMMUNOMODULATING ACTIVITY | 2017 |
|
RU2657819C1 |
| IMMUNOGENIC SUBSTANCES CONTAINING ADJUVANT OF POLYINOSINE ACID AND POLYCYTIDYLIC ACID | 2006 |
|
RU2462264C2 |
| COMPOSITION, STIMULATING IMMUNE RESPONSE, WHICH CONTAINS NANOPARTICLES BASED ON COPOLYMER OF METHYLVINYL ETHER OF MALEIC ANHYDRIDE | 2005 |
|
RU2379028C2 |
| RECOMBINANT PSEUDO-ADENOVIRAL PARTICLE STRAIN EXPRESSING THE CHLAMYDIA TRACHOMATIS CHIMERIC GENE MBL-CT666, A METHOD FOR PREPARING IT, AN IMMUNOGENIC COMPOSITION FOR PROTECTION AGAINST HUMAN UROGENITAL CHLAMYDIOSIS | 2019 |
|
RU2721123C1 |
